宫颈托预防短宫颈双胎妊娠早产:3年随访研究
本研究为ProTWIN随机临床试验的随访研究,纳入2009至2012年多中心试验中孕中期宫颈长度<38 mm的无症状双胎妊娠妇女,比较宫颈托组与对照组儿童在纠正年龄3岁时的死亡及神经发育结局。结果显示宫颈托组死亡及神经发育障碍的累积发生率低于对照组,存活儿童认知、语言和运动发育无显著差异。
要点
- 宫颈托组死亡6例(5%),对照组21例(26%),OR 0.13(95%CI 0.04-0.48)。
- 死亡或存活伴神经发育障碍累积发生率宫颈托组12例(10%)vs对照组23例(29%),OR 0.26(95%CI 0.09-0.73)。
- 存活儿童认知、语言和运动发育两组无统计学或临床相关差异。
核心结论
- 在宫颈长度<38 mm的双胎妊娠妇女中,使用宫颈托明显改善儿童存活率,且未影响纠正年龄3岁时的神经发育。
研究设计与样本
- 本研究为ProTWIN多中心随机试验的随访研究,该试验于2009至2012年纳入无症状多胎妊娠妇女,随机分为放置宫颈托组或无干预组。
- 本随访分析限于孕中期宫颈长度<38 mm的妇女,宫颈托组78例妇女(157名儿童),对照组55例妇女(111名儿童)。
- 在纠正年龄3岁时,存活儿童接受贝利婴幼儿发展量表第三版(Bayley-III)评估。
- 按意向性治疗原则比较两组随机化后死亡或神经发育障碍(Bayley-III评分≤85,即低于均值1个标准差)的发生率,并对缺失数据采用多重插补。
- 采用线性混合效应模型校正同一母亲所生子女间的相关性。
主要发现
- 从进入ProTWIN试验至3岁随访期间,共27名儿童死亡,宫颈托组6例(5%)vs对照组21例(26%),OR 0.13(95%CI 0.04-0.48)。
- 存活儿童中173/241(72%)获得Bayley-III结局数据,宫颈托组114例(75%)vs对照组59例(66%)。
- 死亡或存活伴神经发育障碍的累积发生率宫颈托组12例(10%)vs对照组23例(29%),OR 0.26(95%CI 0.09-0.73)。
- 存活儿童在认知、语言和运动发育方面两组间未发现统计学或临床相关差异。
- 多重插补后得到可比的结果。
关键数值与推荐
- 宫颈长度<38 mm为本文随访分析纳入的孕中期阈值。
- 神经发育障碍定义为Bayley-III评分≤85,即低于均值1个标准差。
- 死亡或神经发育障碍比较采用意向性治疗原则,缺失数据采用多重插补。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A recent randomized clinical trial (ProTWIN) showed that a cervical pessary prevented preterm birth and improved neonatal outcome in women with multiple pregnancy and cervical length (CL) < 38 mm. In this follow-up study, the long-term developmental outcome of these children was evaluated at 3 years' corrected age. METHODS: This was a follow-up study of ProTWIN, a multicenter trial conducted between 2009 and 2012 in which asymptomatic women with a multiple pregnancy were randomized to placement of a cervical pessary or no intervention. Current follow-up and analysis were limited to mothers with a mid-trimester CL < 38 mm (78 women (157 children) in the pessary group and 55 women (111 children) in the control group). At 3 years of corrected age, surviving children were invited for a Bayley Scales of Infant and Toddler Development-third edition (Bayley-III) assessment. Death after randomization or neurodevelopmental disability (Bayley-III score of ≤ 85, 1 SD below mean) rates were compared between the pessary and control groups, according to the intention-to-treat principle and using multiple imputation for missing data. Mean Bayley-III scores in surviving children were also assessed. A linear mixed-effects model was used to adjust for correlation between children of one mother. RESULTS: From the time of entry in the ProTWIN trial until follow-up at 3 years of age, a total of 27 children had died (six (5%) in the pessary vs 21 (26%) in the control group; odds ratio (OR), 0.13; 95% CI, 0.04-0.48). Bayley-III outcomes were collected for 173/241 (72%) surviving children (114 (75%) in the pessary vs 59 (66%) in the control group). The cumulative incidence of death or survival with a neurodevelopmental disability was 12 (10%) in the pessary vs 23 (29%) in the control group (OR, 0.26; 95% CI, 0.09-0.73). No statistical or clinically relevant differences were found with respect to cognitive, language and motor development among surviving children between the groups. Comparable results were found after multiple imputation. CONCLUSION: In women with twin pregnancy and a CL < 38 mm, the use of a cervical pessary strongly improved survival of the children without affecting neurodevelopment at 3 years' corrected age. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.
引用
- van 't Hooft J, van der Lee JH, Opmeer BC, et al. Pessary for prevention of preterm birth in twin pregnancy with short cervix: 3-year follow-up study. Ultrasound Obstet Gynecol. 2018. PMID: 29468770. doi:10.1002/uog.19029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。